Scientists share detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may accelerate the development of antivirals that target this viral structure to ...

Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus). Inmazeb (REGN-EB3), developed by ...

Recent research at the University of Virginia could help provide an important clue as scientists scramble to find a way to treat the Ebola virus. One day after the first Ebola death in the United ...

The model on the left shows how the Ebola virus stalk has a compact conformation, which blocks the site where mAb 3A6 would bind. The model on the right shows how this portion of the stalk can adopt ...

LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus). Inmazeb (REGN-EB3), ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

An outbreak of Ebola disease in Uganda is a result of Sudan virus, the World Health Organization (WHO) has confirmed. Samples from a patient in the Mubende district of central Uganda tested positive ...